Back
Home » Health
  •  
    Filmi Bollywood
    • Kiara Advani Unveils Trailer For Netflix Thriller Film Guilty: Nails Grunge Chic Look
    • Wendell Rodricks’ Husband Jerome Marrel Posts A Heartfelt Note For Late Designer
    • Karan Johar Quashes The Rumours Of Making Student Of The Year 3 With Suhana Khan & Asim Riaz
    • Karan Johar Shuts Down Rumours Of Launching Suhana Khan with Asim Riaz in Student Of The Year 3
    • It’s Official! Taapsee Pannu, Tahir Raj Bhasin To Feature In Hindi Remake Of Run Lola Run
    • Ishaan Khatter Shocked Everyone On Khaali Peeli Set By Doing His Own Stunts, Without Harness
    • Vicky Kaushal On His Ideal Date: ‘My Kind Of Date Is Where It Is Just Me, Her And Nature’
    • Taapsee Pannu Says Success Has Given Her Confidence That Her Choice Of Films Are Right
    • Dabboo Ratnani Shares BTS Videos Of His Calendar Shoot Featuring Vidya Balan, Vicky Kaushal & More
    • Kareena Kapoor Khan Talks About Her Character In Laal Singh Chaddha: People Will Be Shocked
    • Tara Sutaria Reveals She Is Doing Something People Would Not Expect In Her Next Film Tadap
    • Sara Ali Khan Once Wanted To Fake A Cardiac Arrest To Escape Film Narration!
    • Disha Patani Is A Lucky Charm For All Her Co-Stars; Has Given Them Their Biggest Box-Office Hits!
    • Ayushmann Khurrana Is Proud Of India For The Progressiveness It Has Shown
    • Mr. India Trilogy In The Making; Ali Abbas Zafar To Write And Direct
    • Sara Ali Khan Reveals Why She Gets Suspicious Looks From The US Airport Officials
Study Reveals A New Drug May Help Treat Brain Tumours
Boldsky | 12th Aug, 2019 03:23 PM

The research team led by Dr Richard Hill at the Brain Tumour Research Centre at University of Portsmouth (in collaboration with the University of Algarve (Portugal), the University of Liverpool (UK) and Innovate Pharmaceuticals) examined the possible impact of IP1867B in treating a brain tumour, which kills thousands of people every year.

IP1867B, the potential brain cancer treatment drug may help in shrinking brain tumours. The research study was conducted by applying the drug to existing (cancer) treatments and IP1867B was effective in boosting the potency of the treatments and renewed sensitivity to some treatments.

Also read: Artificial Intelligence Can Help Decode Epileptic Brains, Affirms Research

IP1867B can be termed as a revolutionary finding considering the limited success rates of cancer treatments. The limitation of the treatments is due to several factors such as the tumour's ability to develop resistance and hide from the treatment, lack of clinical effectiveness of the treatment, severe side effects and the inability of the medicine to penetrate through the blood-brain barrier. Consequently, during the study, IP1867B was successful at bypassing such factors .

In the study, 'IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R)...adult high-grade gliomas' published in the journal of Cancer Letters suggested that IP1867B - a combination of aspirin, triacetin and saccharin, worked towards reducing the size of adult high-grade glioma brain tumours in a mouse model. Along with that, the drug also helped in reducing the gastrointestinal tract problems caused due to the consumption of conventional aspirin tablets.

Therefore, the researchers asserted that IP1867B could be effective against one of the most aggressive forms of human brain cancer, glioblastoma (GBM). According to Dr Hill, the researcher team head, "To produce a completely new drug takes many years and is very expensive. By focusing our efforts on testing novel formulation techniques, we can move closer to treatment more quickly than would otherwise be possible."

He continued, "We will continue to urgently investigate which drugs will combine most effectively and safely with IP1867B, to improve these results even further and reduce the need for long-term use. There is still much work to be done, but many reasons to be excited about future studies."

The researcher tested various combinations of drugs to understand the most effective treatment, which also included separately testing the three key components of IP1867B. It was found that IP1867B was more effective than some of the chemotherapeutics being used in treatments.

The drug, IP1867B reduced the action of Epidermal Growth Factor Receptor (EGFR) and blocked the Insulin-like Growth Factor 1 pathway. This, in turn, helped reduce the tumour's ability to acquire resistance to the EGFR inhibitors. IP1867B can affect multiple targets, which in turn helps in highlighting the tumour and reverse acquired resistance .

Also read: Medication To Suppress HIV Infection Discovered, Researchers Assert

Dr James Stuart, Medical Director at Innovate Pharmaceuticals asserted, "The next step is to take IP1867B into 'first in human' trial. Innovate are actively driving this next stage of development."

   
 
Health and Life
  • 10 Fruits To Avoid For Diabetes
  • List Of Diseases Caused By Smoking
  • 17 Foods To Eat And Avoid Before Travelling
    • Vitamin K Deficiency: Causes, Symptoms, Diagnosis, Treatment And Prevention
    • 11 Reasons Why You Should Be Drinking Potato Juice
    • 7 Different Ways To Eat Honey For Weight Loss
      • Ways To Use Mint (Pudina) Leaves For Weight Loss
      • 10 Foods To Combat Stomach Gas
      • 8 Morning Habits That Can Cause Weight Gain
        • 7 Risks Associated With Iron Overload
        • 9 Science-backed Benefits Of Intermittent Fasting
        • Top 21 Foods To Build Muscle
          • 10 Healthy Foods To Combat Period Acne
          • 10 Foods To Flush The Nicotine Out Of The Body
          • 7 Benefits Of Eating Poha For Breakfast
            • 10 High Fibre Vegetables To Lose Weight Easily
            • 10 Best Foods With Good Fat For Weight Loss
            • 7 Ways To Include Apple In Your Diet
              • 8 Sour Foods For Weight Loss
              • From Losing Weight To Improving Digestion, Here Are The Impressive Health Benefits Of Hot Water
              • Can You Eat Pani Puri When Trying To Lose Weight?